NO995122L - Anvendelse av <alfa>-metyl-p-tyrosin for å inhibere melaninproduksjon i irismelanocytter - Google Patents

Anvendelse av <alfa>-metyl-p-tyrosin for å inhibere melaninproduksjon i irismelanocytter

Info

Publication number
NO995122L
NO995122L NO995122A NO995122A NO995122L NO 995122 L NO995122 L NO 995122L NO 995122 A NO995122 A NO 995122A NO 995122 A NO995122 A NO 995122A NO 995122 L NO995122 L NO 995122L
Authority
NO
Norway
Prior art keywords
tyrosine
alpha
methyl
melanin production
inhibit melanin
Prior art date
Application number
NO995122A
Other languages
English (en)
Other versions
NO995122D0 (no
Inventor
Filippo Drago
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO995122D0 publication Critical patent/NO995122D0/no
Publication of NO995122L publication Critical patent/NO995122L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO995122A 1997-04-22 1999-10-21 Anvendelse av <alfa>-metyl-p-tyrosin for å inhibere melaninproduksjon i irismelanocytter NO995122L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000939A IT1291633B1 (it) 1997-04-22 1997-04-22 Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride
PCT/EP1998/002365 WO1998047515A1 (en) 1997-04-22 1998-04-21 THE USE OF α-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES

Publications (2)

Publication Number Publication Date
NO995122D0 NO995122D0 (no) 1999-10-21
NO995122L true NO995122L (no) 1999-12-21

Family

ID=11376994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995122A NO995122L (no) 1997-04-22 1999-10-21 Anvendelse av <alfa>-metyl-p-tyrosin for å inhibere melaninproduksjon i irismelanocytter

Country Status (22)

Country Link
US (1) US6359001B1 (no)
EP (1) EP0977575B1 (no)
JP (1) JP2001521540A (no)
KR (1) KR20010020202A (no)
CN (1) CN1255064A (no)
AT (1) ATE227577T1 (no)
AU (1) AU732046B2 (no)
CA (1) CA2287887A1 (no)
DE (1) DE69809408T2 (no)
DK (1) DK0977575T3 (no)
ES (1) ES2187028T3 (no)
HU (1) HUP0002100A3 (no)
IL (1) IL132503A (no)
IT (1) IT1291633B1 (no)
NO (1) NO995122L (no)
NZ (1) NZ500435A (no)
PL (1) PL189304B1 (no)
PT (1) PT977575E (no)
RU (1) RU2218159C2 (no)
SI (1) SI0977575T1 (no)
SK (1) SK284255B6 (no)
WO (1) WO1998047515A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20110280909A1 (en) * 2009-01-29 2011-11-17 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
US9744237B2 (en) * 2009-01-29 2017-08-29 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
US20120076848A1 (en) * 2009-07-22 2012-03-29 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
NZ721280A (en) * 2012-01-17 2017-08-25 Tyme Inc Pharmaceutical compositions and methods for treating cancer
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
ES2738248B2 (es) * 2018-06-21 2023-03-10 Consejo Superior Investigacion Uso de inhibidores de la tirosina hidroxilasa para el tratamiento del aneurisma de aorta
US11534420B2 (en) 2019-05-14 2022-12-27 Tyme, Inc. Compositions and methods for treating cancer
CN116035151A (zh) * 2023-01-18 2023-05-02 云南贝泰妮生物科技集团股份有限公司 一种刺梨闪释粉及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04117313A (ja) * 1990-09-06 1992-04-17 Kanebo Ltd 美白化粧料

Also Published As

Publication number Publication date
ITMI970939A0 (no) 1997-04-22
PL336386A1 (en) 2000-06-19
KR20010020202A (ko) 2001-03-15
IL132503A0 (en) 2001-03-19
DE69809408D1 (de) 2002-12-19
PL189304B1 (pl) 2005-07-29
SK142499A3 (en) 2000-09-12
JP2001521540A (ja) 2001-11-06
CN1255064A (zh) 2000-05-31
ATE227577T1 (de) 2002-11-15
IL132503A (en) 2004-06-20
RU2218159C2 (ru) 2003-12-10
EP0977575A1 (en) 2000-02-09
IT1291633B1 (it) 1999-01-11
CA2287887A1 (en) 1998-10-29
EP0977575B1 (en) 2002-11-13
ITMI970939A1 (it) 1998-10-22
US6359001B1 (en) 2002-03-19
WO1998047515A1 (en) 1998-10-29
ES2187028T3 (es) 2003-05-16
DK0977575T3 (da) 2003-03-10
DE69809408T2 (de) 2003-07-10
HUP0002100A3 (en) 2003-05-28
NO995122D0 (no) 1999-10-21
PT977575E (pt) 2003-03-31
AU7646298A (en) 1998-11-13
AU732046B2 (en) 2001-04-12
NZ500435A (en) 2001-09-28
SK284255B6 (sk) 2004-12-01
SI0977575T1 (en) 2003-04-30
HUP0002100A2 (hu) 2000-11-28

Similar Documents

Publication Publication Date Title
NO995122L (no) Anvendelse av &lt;alfa&gt;-metyl-p-tyrosin for å inhibere melaninproduksjon i irismelanocytter
DE3781571D1 (de) Aufbereitung superreinen wassers mittels fotokatalyse.
ATE172634T1 (de) Hemmen von haarwuchs
MX9306205A (es) Mejoras en o relacionadas con las composiciones cosmesticas.
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
ATE203016T1 (de) Cryptophycine
PT1242410E (pt) Compostos novos
DK0504335T3 (da) Fibronectinbindende peptid
NZ299006A (en) Use of 4-dichlorophenyl tetrahydro N-methyl-1-naphthalenamine (sertraline) for heart attack treatment
DE69430074D1 (de) Analgetische 4-arylisoindolen
DE50006414D1 (de) Mistelextrakte in hautkosmetika
AU118002S (en) Bathing towel/garment
FI962568A (fi) Turvajärjestelyn käyttö ja turvajärjestely yleisen turvallisuuden parantamiseksi
IT8614909V0 (it) Pannelli doppi-faccia per pubblici ta&#39;fissa ed affissione manifesti, da agganciare ai pali della pubblica illuminazione
IT238155Y1 (it) Water e bide&#39; unificati senza che l&#39;utente debba spostarsi perusufruire dei due servizi
ID17905A (id) Mempernis ulang goresan-goresan pada tutup lingkaran yang mudah dibuka
ES2148057A1 (es) Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3
BR9302550A (pt) Modelo de cripto-sistema de chave pública

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application